1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD

Show Description +

Charles Wykoff, MD, PhD, shares the 1-year primary outcome data from the RECOVERY trial, which examined aflibercept in patients with PDR, extensive nonperfusion, and no DME.

Posted: 7/11/2019

Up Next

Name: 1-Year Primary Outcome Data From RECOVERY
Uploaded: 2019-07-11T11:37:00+00:00
Description: Charles Wykoff, MD, PhD, shares the 1-year primary outcome data from the RECOVERY trial, which examined aflibercept in patients with PDR, extensive nonperfusion, and no DME.

Ranibizumab PDS: How LADDER Informed ARCHWAY

Arshad Khanani, MD

Intravitreal Injections and Clinical Resources

Christina Weng, MD

CST Fluctuations in HAWK and HARRIER

Chirag Jhaveri, MD

STAIRWAY: Faricimab for Wet AMD

Philip Ferrone

HARBOR Post-Hoc Analysis: Vision Outcomes and the Presence of Fluid

Nancy Holekamp, MD

Preview to ASRS with Dr. Packo

Kirk Packo, MD

Preview to ASRS 2019 With Dr. Pollack

John Pollack, MD

Higher-Level Analysis of OCT Features

Justis Ehlers, MD

The Winning Pitch: The Shark Tank of Retina

David Williams

Rethinking Risk in Fovea-Sparing RRDs

James Major Jr., MD

What Happens When DR Treatment Is Less Aggressive?

Roger A. Goldberg, MD, MBA

Hyperreflective Foci and Pathologic Risk

Bozho Todorich, MD, PhD

Novel Combination Technique for Closing Challenging Macular Holes

Robert Sisk

A Novel Retinal Tamponade

Tommy Stryjewski, Tony Stefater

Back to All Videos

1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD

Charles Wykoff, MD, PhD, shares the 1-year primary outcome data from the RECOVERY trial, which examined aflibercept in patients with PDR, extensive nonperfusion, and no DME.

Posted: 7/11/2019

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

1-Year Primary Outcome Data From RECOVERY

Up Next

1-Year Primary Outcome Data From RECOVERY

More From ASRS: 2019 Coverage